News

Open Call Innovation Focus Areas

Published on: 29/03/2020

Open Call Innovation Focus Areas
Covid-19, Demand, Funding
Member News, Funding news

COVID-19: Rapid Sanitising Technology

Unique Identifier IFA019

Ambulances must be thoroughly cleaned once a patient with suspected COVID-19 has been transported. These cleaning times can take up to 45 minutes and have to be undertaken at cleaning centres which can be some distance away. This puts a strain on an already busy and pressurised service as the vehicles cannot be used until cleaning is completed.

We are looking to identify, develop and demonstrate rapid sanitising technologies. All projects will be required to undergo practical assessment at Dstl Porton Down and a live demonstration on an ambulance, provided by the Welsh Ambulance Service.

Innovations must be suitable for rapid deployment to clean public sector vehicles following the transport of patients with the COVID-19 virus. Ideally systems will have wider applicability than just ambulances, which might include buses, trains, and other blue light services or even in hospital wards / rooms.

Systems which are mobile, allow ease of operation and maintenance, are robust and reliable are of particular interest.

If your idea relies on use of decontaminants, it must be able to fully wet a complex surface for a given contact time to ensure it’s decontaminated effectively. If you do not have access to a suitable decontaminant, please specify this in your proposal.

Efficacy will need to be demonstrated via a short process of trials/experimentation, to include definition of tactics, techniques and procedures (TTPs) to ensure selected options are used effectively for specific applications. We need ideas that can rapidly be developed and tested with potential to be scaled and used across the UK over the coming months.

Direct contracts will be placed by the SBRI Centre of ExcellenceDASA will be handling the assessment of your proposal and will be passing proposals to the SBRI Centre of Excellence for contract placement. There may be occasions where additional funding subsequently becomes available. In these circumstances, DASA reserves the right to offer contracts under the standard terms and conditions subsequent to the original awards.

The information you provide to us as part of your proposal, that is not already available to us from other sources, will be handled in confidence. As part of the assessment process, DASA reserves the right to disclose on a confidential basis any information it receives from you, to any third party engaged by DASA for the specific purpose of evaluating or assisting DASA in the evaluation of your proposal. Appropriate confidentiality agreements will be put in place.

In providing your proposal you are consenting to these provisions.

If you have an idea but you are not sure if it is what we are looking for, please contact a DASA Innovation Partner.

Submit your proposal here.

NEWS​

Related News

Schiltron.io: tech-enabled hardware provider to meet the needs of different health and care environments

10 Mar 2025
Schiltron.io offers a versatile and intelligent portfolio of products and services with a range of smart accessories to meet the needs of different he...

Join the AccessCoVE International Cooperation Network

5 Mar 2025
Gnomon’s role in the European Centre of Vocational Excellence in Accessibility (AccessCoVE) is to bring its expertise in the field of software develop...

Bulgarian Joint Cancer Network: advancing cancer prevention, diagnosis and treatment

5 Mar 2025
The Bulgarian Joint Cancer Network (BJCN) plays a crucial role in national and European initiatives, supporting evidence-based policymaking, digital h...

Parkinson’s UK: Drug accelerator awards

4 Mar 2025
Parkinson's UK looking for projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson...

Healthcare Infection Society: Major Research Grant

4 Mar 2025

2025 Debra: The Butterfly Skin Charity

4 Mar 2025
DEBRA UK wants to fund you to help create a world where no one suffers with epidermolysis bullosa (EB). This painful and life-limiting condition affec...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *